Cytovance® Biologics is a leading US-based biopharmaceutical Contract Development and Manufacturing Organization that brings decades of innovation and ingenuity to international customers looking for unrivaled large molecule biologics support from protein to patient. In addition to mammalian expression and manufacturing services, the Cytovance team provides world-class microbial strain, process development, and cGMP manufacturing with a 95% scale-up success rate. The company’s 140,000+ sq. ft state-of-the-art facilities are designed to meet global regulatory requirements and have an exceptional FDA audit record that has enabled customers to produce regulatory-approved antibodies, fusion proteins, enzymes, vaccines, recombinant proteins, and others for critical medical needs.